| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intensive Care Units, Neonatal | 27 | 2026 | 350 | 6.190 |
Why?
|
| Infant, Premature | 15 | 2026 | 861 | 2.930 |
Why?
|
| Infant, Newborn | 59 | 2026 | 8551 | 2.140 |
Why?
|
| Infant, Premature, Diseases | 7 | 2024 | 252 | 2.020 |
Why?
|
| Hypoxia-Ischemia, Brain | 11 | 2025 | 93 | 1.960 |
Why?
|
| Infant, Extremely Premature | 8 | 2024 | 113 | 1.510 |
Why?
|
| Noise | 2 | 2023 | 17 | 1.430 |
Why?
|
| Bronchopulmonary Dysplasia | 6 | 2026 | 217 | 1.300 |
Why?
|
| Erythropoietin | 6 | 2022 | 102 | 1.280 |
Why?
|
| Infant, Newborn, Diseases | 3 | 2021 | 177 | 1.190 |
Why?
|
| Gestational Age | 14 | 2025 | 1209 | 1.190 |
Why?
|
| Hypothermia, Induced | 7 | 2025 | 168 | 1.120 |
Why?
|
| Cardiopulmonary Resuscitation | 2 | 2021 | 228 | 1.040 |
Why?
|
| Child Development | 3 | 2023 | 267 | 1.010 |
Why?
|
| Lung Diseases | 2 | 2022 | 397 | 0.960 |
Why?
|
| Heart Arrest | 2 | 2021 | 354 | 0.940 |
Why?
|
| Pregnancy Complications, Infectious | 4 | 2025 | 503 | 0.900 |
Why?
|
| Lateral Ventricles | 1 | 2025 | 16 | 0.880 |
Why?
|
| Parents | 5 | 2026 | 1116 | 0.800 |
Why?
|
| Hypoglycemia | 3 | 2021 | 183 | 0.790 |
Why?
|
| Infant | 26 | 2025 | 13276 | 0.780 |
Why?
|
| Anticonvulsants | 2 | 2024 | 362 | 0.740 |
Why?
|
| Vasodilator Agents | 2 | 2026 | 197 | 0.720 |
Why?
|
| Tocolytic Agents | 1 | 2022 | 11 | 0.720 |
Why?
|
| Brain Diseases | 1 | 2025 | 298 | 0.720 |
Why?
|
| Needs Assessment | 1 | 2023 | 173 | 0.710 |
Why?
|
| Phenobarbital | 1 | 2021 | 30 | 0.700 |
Why?
|
| Visitors to Patients | 1 | 2020 | 9 | 0.650 |
Why?
|
| Incubators, Infant | 1 | 2020 | 4 | 0.650 |
Why?
|
| Hospital Administration | 1 | 2020 | 23 | 0.650 |
Why?
|
| Papaver | 1 | 2020 | 4 | 0.650 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2023 | 206 | 0.640 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 2020 | 22 | 0.630 |
Why?
|
| Anemia, Neonatal | 1 | 2019 | 8 | 0.620 |
Why?
|
| Neonatology | 3 | 2025 | 64 | 0.620 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2020 | 60 | 0.620 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2019 | 61 | 0.600 |
Why?
|
| Humans | 62 | 2026 | 130154 | 0.600 |
Why?
|
| Neuroprotection | 1 | 2019 | 32 | 0.600 |
Why?
|
| Infection Control | 1 | 2020 | 156 | 0.590 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2019 | 40 | 0.580 |
Why?
|
| United States | 16 | 2026 | 11885 | 0.570 |
Why?
|
| Hypernatremia | 1 | 2019 | 32 | 0.560 |
Why?
|
| Epoprostenol | 1 | 2018 | 34 | 0.560 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2022 | 395 | 0.550 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2020 | 260 | 0.550 |
Why?
|
| Hyponatremia | 1 | 2019 | 72 | 0.550 |
Why?
|
| Infant, Low Birth Weight | 4 | 2025 | 169 | 0.540 |
Why?
|
| Sodium | 1 | 2019 | 279 | 0.530 |
Why?
|
| Fertilization in Vitro | 1 | 2019 | 152 | 0.520 |
Why?
|
| Betacoronavirus | 1 | 2020 | 273 | 0.520 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2018 | 86 | 0.510 |
Why?
|
| Retrospective Studies | 15 | 2025 | 17554 | 0.470 |
Why?
|
| Nitric Oxide | 2 | 2018 | 466 | 0.470 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 338 | 0.460 |
Why?
|
| Pregnancy Outcome | 1 | 2019 | 614 | 0.460 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 349 | 0.460 |
Why?
|
| Neonatologists | 2 | 2025 | 22 | 0.450 |
Why?
|
| Resuscitation | 1 | 2017 | 259 | 0.440 |
Why?
|
| Female | 35 | 2026 | 70285 | 0.440 |
Why?
|
| Pregnancy | 12 | 2025 | 7396 | 0.440 |
Why?
|
| Mass Screening | 1 | 2020 | 812 | 0.430 |
Why?
|
| Patient Selection | 3 | 2026 | 722 | 0.420 |
Why?
|
| Hemorrhage | 1 | 2018 | 486 | 0.420 |
Why?
|
| Biomedical Research | 3 | 2026 | 556 | 0.410 |
Why?
|
| Pandemics | 1 | 2020 | 1114 | 0.390 |
Why?
|
| Electroencephalography | 4 | 2025 | 849 | 0.380 |
Why?
|
| Hypothermia | 2 | 2023 | 60 | 0.380 |
Why?
|
| Cross-Sectional Studies | 7 | 2024 | 3781 | 0.370 |
Why?
|
| Milk, Human | 3 | 2021 | 318 | 0.370 |
Why?
|
| Surveys and Questionnaires | 7 | 2025 | 4032 | 0.360 |
Why?
|
| Typhoid Fever | 1 | 2011 | 18 | 0.350 |
Why?
|
| Salmonella typhi | 1 | 2011 | 21 | 0.350 |
Why?
|
| Retinopathy of Prematurity | 2 | 2024 | 64 | 0.340 |
Why?
|
| Male | 27 | 2026 | 64397 | 0.340 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2011 | 158 | 0.310 |
Why?
|
| Informed Consent | 2 | 2026 | 351 | 0.310 |
Why?
|
| Prevalence | 4 | 2025 | 2685 | 0.300 |
Why?
|
| Texas | 3 | 2025 | 3648 | 0.290 |
Why?
|
| Dietary Supplements | 4 | 2024 | 445 | 0.270 |
Why?
|
| Decision Making | 3 | 2026 | 711 | 0.250 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2025 | 629 | 0.250 |
Why?
|
| Premature Birth | 2 | 2022 | 419 | 0.240 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2026 | 34 | 0.240 |
Why?
|
| Sildenafil Citrate | 1 | 2026 | 56 | 0.240 |
Why?
|
| Sulfones | 1 | 2026 | 72 | 0.240 |
Why?
|
| Cerebral Palsy | 2 | 2024 | 86 | 0.230 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2026 | 62 | 0.230 |
Why?
|
| Syphilis, Congenital | 1 | 2025 | 32 | 0.220 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2026 | 80 | 0.220 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2025 | 135 | 0.220 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2025 | 85 | 0.210 |
Why?
|
| Piperazines | 1 | 2026 | 269 | 0.210 |
Why?
|
| Research Personnel | 1 | 2025 | 139 | 0.200 |
Why?
|
| Incubators | 1 | 2023 | 2 | 0.200 |
Why?
|
| Seizures | 3 | 2024 | 874 | 0.200 |
Why?
|
| Sound | 1 | 2023 | 19 | 0.200 |
Why?
|
| Vitamin D Deficiency | 1 | 2024 | 81 | 0.200 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2024 | 88 | 0.200 |
Why?
|
| Birth Weight | 3 | 2022 | 345 | 0.190 |
Why?
|
| Weight Gain | 2 | 2023 | 384 | 0.190 |
Why?
|
| Oximetry | 1 | 2024 | 176 | 0.190 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2002 | 37 | 0.190 |
Why?
|
| Vitamin D | 1 | 2024 | 192 | 0.190 |
Why?
|
| Palivizumab | 1 | 2022 | 48 | 0.180 |
Why?
|
| Cohort Studies | 5 | 2025 | 5042 | 0.180 |
Why?
|
| Tocolysis | 1 | 2022 | 5 | 0.180 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2002 | 109 | 0.180 |
Why?
|
| Mothers | 1 | 2025 | 378 | 0.180 |
Why?
|
| Administration, Intravenous | 2 | 2022 | 170 | 0.180 |
Why?
|
| Status Epilepticus | 1 | 2023 | 159 | 0.180 |
Why?
|
| Magnesium Sulfate | 1 | 2022 | 52 | 0.170 |
Why?
|
| Phenytoin | 1 | 2021 | 54 | 0.170 |
Why?
|
| Double-Blind Method | 5 | 2026 | 1618 | 0.170 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2022 | 81 | 0.170 |
Why?
|
| Refusal to Participate | 1 | 2021 | 3 | 0.170 |
Why?
|
| Breast Feeding | 2 | 2021 | 234 | 0.170 |
Why?
|
| Neuroprotective Agents | 1 | 2022 | 158 | 0.170 |
Why?
|
| Parental Consent | 1 | 2021 | 24 | 0.160 |
Why?
|
| Patients' Rooms | 1 | 2020 | 8 | 0.160 |
Why?
|
| Placenta Diseases | 1 | 2021 | 53 | 0.160 |
Why?
|
| Hospital Design and Construction | 1 | 2020 | 12 | 0.160 |
Why?
|
| Probiotics | 1 | 2023 | 227 | 0.160 |
Why?
|
| Equipment Safety | 1 | 2020 | 34 | 0.160 |
Why?
|
| Tea | 1 | 2020 | 17 | 0.160 |
Why?
|
| Infant Health | 1 | 2020 | 17 | 0.160 |
Why?
|
| Oxygen | 1 | 2024 | 549 | 0.160 |
Why?
|
| Policy Making | 1 | 2020 | 60 | 0.160 |
Why?
|
| Organizational Policy | 1 | 2020 | 50 | 0.160 |
Why?
|
| Codeine | 1 | 2020 | 23 | 0.160 |
Why?
|
| Manikins | 1 | 2020 | 44 | 0.160 |
Why?
|
| Echoencephalography | 1 | 2020 | 28 | 0.160 |
Why?
|
| Stress, Psychological | 1 | 2025 | 533 | 0.160 |
Why?
|
| Morphine | 1 | 2020 | 80 | 0.160 |
Why?
|
| Cholestasis | 1 | 2022 | 170 | 0.160 |
Why?
|
| Seeds | 1 | 2020 | 44 | 0.160 |
Why?
|
| Registries | 2 | 2025 | 1610 | 0.160 |
Why?
|
| Drug Evaluation | 1 | 2019 | 101 | 0.160 |
Why?
|
| Child, Preschool | 7 | 2025 | 15009 | 0.150 |
Why?
|
| Kangaroo-Mother Care Method | 1 | 2019 | 3 | 0.150 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2021 | 150 | 0.150 |
Why?
|
| Patient Care Bundles | 1 | 2019 | 21 | 0.150 |
Why?
|
| Intubation, Intratracheal | 1 | 2021 | 212 | 0.150 |
Why?
|
| Rhombencephalon | 2 | 2009 | 63 | 0.150 |
Why?
|
| Pregnancy, Multiple | 1 | 2019 | 44 | 0.140 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2020 | 169 | 0.140 |
Why?
|
| Physicians | 1 | 2025 | 627 | 0.140 |
Why?
|
| Blood Transfusion | 1 | 2020 | 291 | 0.140 |
Why?
|
| Blood Gas Analysis | 1 | 2018 | 86 | 0.140 |
Why?
|
| Food, Fortified | 1 | 2018 | 63 | 0.140 |
Why?
|
| Eye Diseases | 1 | 2019 | 106 | 0.140 |
Why?
|
| Eating | 1 | 2020 | 375 | 0.130 |
Why?
|
| Administration, Inhalation | 1 | 2018 | 192 | 0.130 |
Why?
|
| Pulmonary Surfactants | 1 | 2018 | 45 | 0.130 |
Why?
|
| Phospholipids | 1 | 2018 | 99 | 0.130 |
Why?
|
| Hospitals | 1 | 2020 | 431 | 0.130 |
Why?
|
| Brain Injuries | 1 | 2022 | 703 | 0.120 |
Why?
|
| Neuroimaging | 1 | 2020 | 380 | 0.120 |
Why?
|
| Antiviral Agents | 1 | 2022 | 800 | 0.120 |
Why?
|
| Infant Mortality | 1 | 2018 | 181 | 0.120 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2021 | 402 | 0.120 |
Why?
|
| Enteral Nutrition | 1 | 2019 | 286 | 0.120 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 1121 | 0.120 |
Why?
|
| Biological Products | 1 | 2018 | 143 | 0.120 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2018 | 331 | 0.110 |
Why?
|
| Treatment Outcome | 5 | 2026 | 12843 | 0.110 |
Why?
|
| Adult | 6 | 2026 | 31042 | 0.110 |
Why?
|
| Child | 4 | 2024 | 26181 | 0.110 |
Why?
|
| Liver | 1 | 2002 | 1788 | 0.110 |
Why?
|
| Membrane Proteins | 1 | 2002 | 1588 | 0.110 |
Why?
|
| Glucose | 1 | 2019 | 851 | 0.110 |
Why?
|
| Severity of Illness Index | 2 | 2026 | 3025 | 0.110 |
Why?
|
| Acute Kidney Injury | 1 | 2022 | 700 | 0.110 |
Why?
|
| Logistic Models | 1 | 2019 | 1793 | 0.110 |
Why?
|
| Blood Glucose | 1 | 2018 | 1108 | 0.100 |
Why?
|
| Databases, Factual | 1 | 2019 | 1230 | 0.100 |
Why?
|
| Sex Factors | 1 | 2018 | 1337 | 0.100 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2022 | 848 | 0.100 |
Why?
|
| Epilepsy | 1 | 2021 | 864 | 0.100 |
Why?
|
| Hospitalization | 1 | 2022 | 1934 | 0.100 |
Why?
|
| Feeding Behavior | 1 | 2019 | 708 | 0.100 |
Why?
|
| Trust | 2 | 2026 | 88 | 0.090 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2025 | 1262 | 0.090 |
Why?
|
| Biomarkers | 2 | 2020 | 3360 | 0.090 |
Why?
|
| Case-Control Studies | 1 | 2019 | 3350 | 0.090 |
Why?
|
| Pakistan | 1 | 2011 | 99 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2026 | 1606 | 0.080 |
Why?
|
| Proprioception | 1 | 2009 | 17 | 0.080 |
Why?
|
| Periodicity | 1 | 2009 | 48 | 0.080 |
Why?
|
| Arousal | 1 | 2009 | 74 | 0.080 |
Why?
|
| Heart Defects, Congenital | 1 | 2021 | 1880 | 0.080 |
Why?
|
| Respiratory Mechanics | 1 | 2009 | 80 | 0.070 |
Why?
|
| Time Factors | 1 | 2018 | 6178 | 0.070 |
Why?
|
| Morphogenesis | 1 | 2008 | 185 | 0.070 |
Why?
|
| Recurrence | 1 | 2011 | 1476 | 0.070 |
Why?
|
| Interneurons | 1 | 2008 | 144 | 0.060 |
Why?
|
| Spinal Cord | 1 | 2008 | 256 | 0.060 |
Why?
|
| Risk Factors | 3 | 2022 | 10953 | 0.060 |
Why?
|
| Neonatal Nursing | 1 | 2026 | 6 | 0.060 |
Why?
|
| Asphyxia Neonatorum | 1 | 2025 | 23 | 0.060 |
Why?
|
| Brain | 3 | 2024 | 3146 | 0.060 |
Why?
|
| Purines | 1 | 2026 | 115 | 0.060 |
Why?
|
| Research Support as Topic | 1 | 2025 | 61 | 0.060 |
Why?
|
| Penicillins | 1 | 2025 | 153 | 0.050 |
Why?
|
| Job Satisfaction | 1 | 2025 | 99 | 0.050 |
Why?
|
| Prospective Studies | 3 | 2021 | 6403 | 0.050 |
Why?
|
| Hypotension | 1 | 2026 | 186 | 0.050 |
Why?
|
| Mother-Child Relations | 1 | 2025 | 83 | 0.050 |
Why?
|
| Interviews as Topic | 1 | 2026 | 452 | 0.050 |
Why?
|
| Stem Cells | 1 | 2008 | 704 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2025 | 276 | 0.050 |
Why?
|
| Career Choice | 1 | 2025 | 167 | 0.050 |
Why?
|
| Health Care Surveys | 1 | 2024 | 276 | 0.050 |
Why?
|
| Postpartum Period | 1 | 2025 | 238 | 0.050 |
Why?
|
| Neurons | 2 | 2009 | 1979 | 0.050 |
Why?
|
| Mice, Knockout | 3 | 2009 | 3814 | 0.050 |
Why?
|
| Asphyxia | 1 | 2022 | 14 | 0.050 |
Why?
|
| Hemochromatosis Protein | 1 | 2002 | 22 | 0.050 |
Why?
|
| Hepcidins | 1 | 2002 | 26 | 0.050 |
Why?
|
| Olive Oil | 1 | 2022 | 24 | 0.050 |
Why?
|
| Indomethacin | 1 | 2022 | 78 | 0.050 |
Why?
|
| Soybean Oil | 1 | 2022 | 71 | 0.050 |
Why?
|
| Albumins | 1 | 2022 | 88 | 0.050 |
Why?
|
| Qualitative Research | 1 | 2026 | 708 | 0.050 |
Why?
|
| Fish Oils | 1 | 2022 | 82 | 0.040 |
Why?
|
| Albuminuria | 1 | 2022 | 106 | 0.040 |
Why?
|
| Bilirubin | 1 | 2022 | 124 | 0.040 |
Why?
|
| Spleen | 1 | 2002 | 258 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2024 | 3744 | 0.040 |
Why?
|
| Hydrops Fetalis | 1 | 2021 | 82 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 5161 | 0.040 |
Why?
|
| Patient Safety | 1 | 2025 | 444 | 0.040 |
Why?
|
| Administration, Buccal | 1 | 2019 | 5 | 0.040 |
Why?
|
| Outpatients | 1 | 2021 | 263 | 0.040 |
Why?
|
| Triglycerides | 1 | 2022 | 601 | 0.040 |
Why?
|
| Length of Stay | 1 | 2025 | 1406 | 0.040 |
Why?
|
| Patient Acuity | 1 | 2019 | 66 | 0.040 |
Why?
|
| Bevacizumab | 1 | 2019 | 59 | 0.040 |
Why?
|
| Pacifiers | 1 | 2019 | 4 | 0.040 |
Why?
|
| Iron | 1 | 2022 | 306 | 0.040 |
Why?
|
| Animals | 5 | 2025 | 33698 | 0.040 |
Why?
|
| Glutamic Acid | 2 | 2009 | 192 | 0.040 |
Why?
|
| Blood Urea Nitrogen | 1 | 2018 | 69 | 0.040 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2019 | 112 | 0.040 |
Why?
|
| Steroids | 1 | 2019 | 169 | 0.040 |
Why?
|
| Acute Disease | 1 | 2021 | 1157 | 0.030 |
Why?
|
| Vomiting | 1 | 2018 | 103 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2018 | 408 | 0.030 |
Why?
|
| Incidence | 1 | 2025 | 3314 | 0.030 |
Why?
|
| Acidosis | 1 | 2018 | 97 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2021 | 512 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2023 | 776 | 0.030 |
Why?
|
| Laser Therapy | 1 | 2019 | 241 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2018 | 563 | 0.030 |
Why?
|
| Mice | 4 | 2009 | 18172 | 0.030 |
Why?
|
| Prenatal Care | 1 | 2019 | 343 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2002 | 2553 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2021 | 1241 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2019 | 387 | 0.030 |
Why?
|
| Retina | 1 | 2019 | 423 | 0.030 |
Why?
|
| Prognosis | 1 | 2025 | 4848 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2025 | 3680 | 0.030 |
Why?
|
| Cell Movement | 2 | 2009 | 875 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2020 | 943 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2009 | 2329 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2025 | 2577 | 0.020 |
Why?
|
| Hypoventilation | 1 | 2009 | 12 | 0.020 |
Why?
|
| Auditory Pathways | 1 | 2009 | 20 | 0.020 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2009 | 48 | 0.020 |
Why?
|
| Somatostatin | 1 | 2009 | 60 | 0.020 |
Why?
|
| Auditory Perception | 1 | 2009 | 39 | 0.020 |
Why?
|
| Medulla Oblongata | 1 | 2009 | 24 | 0.020 |
Why?
|
| Acetylcholine | 1 | 2009 | 69 | 0.020 |
Why?
|
| Levodopa | 1 | 2009 | 91 | 0.020 |
Why?
|
| LIM-Homeodomain Proteins | 1 | 2008 | 28 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2009 | 358 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2009 | 806 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2009 | 272 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2008 | 436 | 0.020 |
Why?
|
| Neurogenesis | 1 | 2009 | 210 | 0.020 |
Why?
|
| Nerve Net | 1 | 2009 | 254 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2008 | 558 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2009 | 951 | 0.010 |
Why?
|
| Middle Aged | 1 | 2025 | 28331 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2008 | 2404 | 0.010 |
Why?
|